Abstract

In diabetes mellitus type 2 (DM2), developed obesity is referred to as diabesity. Implementation of a healthy diet, such as the Mediterranean, prevents diabesity. Saffron is frequently used in this diet because of its bioactive components, such as crocetin (CCT), exhibit healthful properties. It is well known that obesity, defined as an excessive accumulation of fat, leads to cardiometabolic pathology through adiposopathy or hypertrophic growth of adipose tissue (AT).This is related to an impaired adipogenic process or death of adipocytes by obesogenic signals. We aimed to evaluate the effect of the pathogenic microenvironment and CCT, activating differentiation of healthy preadipocytes (PA). For this, we used human cryopreserved PA from visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) depots obtained from healthy and obese-DM2 donors. We studied the effect of a metabolically detrimental (diabesogenic) environment, generated by obese-DM2 adipocytes from VAT (VdDM) or SAT (SdDM), on the viability and accumulation of intracellular fat of adipocytes differentiated from healthy PA, in the presence or absence of CCT (1 or 10 μM). Intracellular fat was quantified by Oil Red O staining. Cytotoxicity was measured using the MTT assay. Our results showed that diabesogenic conditions induce cytotoxicity and provide a proadipogenic environment only for visceral PA. CCT at 10 μM acted as an antiadipogenic and cytoprotective compound.

Highlights

  • Type 2 diabetes mellitus (DM2) is a metabolic disorder mainly characterized by insulin resistance (IR) and abnormal insulin secretion by pancreatic cells β [1]

  • We aimed to evaluate if the differentiation of new adipocytes within each depot is impaired when it is activated by a potential pathogenic microenvironment, and if CCT has any ability to restore this possible impairment

  • We studied the effect of these pathological microenvironments on the viability and accumulation of intracellular fat of adipocytes differentiated from PA obtained from visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) depots of healthy, non-obese individuals, in the presence or absence of CCT

Read more

Summary

Introduction

Type 2 diabetes mellitus (DM2) is a metabolic disorder mainly characterized by insulin resistance (IR) and abnormal insulin secretion by pancreatic cells β [1]. It is currently considered a major public health problem with significant social and economic impacts. The World Health Organization defines obesity as an abnormal or excessive accumulation of fat (adiposity) that can be a risk factor for suffering DM2, cardiovascular disease, or cancer [4,5] There are both metabolically healthy obese individuals and lean metabolically obese subjects [6], as well as obese and non-obese DM2 patients [7]. It appears that the pathogenesis of obesity is not just a matter of fat quantity, and of adipose tissue (AT) dysfunction, which is known as adiposopathy [4]

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call